Medicine

Alto Neuroscience’s depression drug seems effective in early trials, a proof-of-concept for biomarker-based design.

BioNTech is sending a modular mRNA vaccine factory that can produce 50 million COVID-19 vaccines annually to Africa.

Moderna’s mRNA RSV vaccine for adults looks to be over 80% effective, based on early data from a large phase 3 trial.

A new delivery method for mRNA therapies could open the doors to better treatments for aging, cancer, and more.

A “morning after” antiviral nasal spray could be created using new knowledge about how SARS-CoV-2 invades your nose.

After a monumental year of breakthroughs, scientists, investors, and CEOs share which areas of biotech they are eagerly watching this year.

Kira Peikoff

MRI-guided focused ultrasound has been used to deliver chemo into the brain of a pediatric cancer patient for the first time.

A new hypothesis suggests that Alzheimer's disease is the result of "jumping genes" in the brain, not inflammation or plaque.

Mo Costandi

Researchers have resurrected an ancient CRISPR system 2.6 billion years old, capable of editing genes in the modern day.

Verily, owned by Google parent company Alphabet, believes it can eliminate Singapore’s dengue problem.